Home / 2013 MDF Annual Conference - How Antisense Oligonucleotides are Designed to Work

2013 MDF Annual Conference - How Antisense Oligonucleotides are Designed to Work

Dr. Bruce Wentworth, Ph.D., of Genzyme, presents an overview of  ASO treatments, describing in lay language how they are intended to treat DM.


(View a PDF of Dr. Wentworth's presentation)

Partners

© Myotonic Dystrophy Foundation. All rights reserved.